Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Quest Diagnostics Inc (NYSE:DGX)

109.70
Delayed Data
As of Jun 23
 +0.14 / +0.13%
Today’s Change
77.29
Today|||52-Week Range
110.38
+19.37%
Year-to-Date
Quality Stocks in Gurus' Portfolios
Jun 23 / GuruFocus News - Paid Partner Content
Why You Should Avoid Envision Healthcare (EVHC) Stock Now
Jun 15 / Zacks.com - Paid Partner Content
Why Quest Diagnostics (DGX) is a Suitable Pick for Investors
Jun 22 / Zacks.com - Paid Partner Content
Quest Diagnostics to Buy 2 Labs, Grow in Oncology Space
Jun 13 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close109.56
Today’s open109.66
Day’s range109.01 - 109.89
Volume1,260,543
Average volume (3 months)862,228
Market cap$15.0B
Dividend yield1.64%
Data as of 4:01pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-7.16%
Earnings growth (this year)+8.10%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+0.29%
P/E ratio22.1
Price/Sales1.74
Price/Book3.25

Competitors

 Today’s
change
Today’s
% change
LHLaboratory Corporati...+1.28+0.85%
FMIFoundation Medicine ...+0.65+1.54%
GHDXGenomic Health Inc-0.20-0.60%
KANGiKang Healthcare Gro...-0.80-5.57%
Data as of 4:02pm ET, 06/23/2017

Financials

Next reporting dateJuly 25, 2017
EPS forecast (this quarter)$1.42
Annual revenue (last year)$7.5B
Annual profit (last year)$642.0M
Net profit margin8.54%

Profile

Sector
Health Services
Industry
Services to the Health Industry
Chairman, President &
Chief Executive Officer
Stephen H. Rusckowski
Chief Financial Officer &
Senior Vice President
Mark J. Guinan
Corporate headquarters
Madison, New Jersey

Forecasts